These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tertiary lymphoid structures in cancer and beyond. Dieu-Nosjean MC; Goc J; Giraldo NA; Sautès-Fridman C; Fridman WH Trends Immunol; 2014 Nov; 35(11):571-80. PubMed ID: 25443495 [TBL] [Abstract][Full Text] [Related]
4. The immune contexture of primary and metastatic human tumours. Giraldo NA; Becht E; Remark R; Damotte D; Sautès-Fridman C; Fridman WH Curr Opin Immunol; 2014 Apr; 27():8-15. PubMed ID: 24487185 [TBL] [Abstract][Full Text] [Related]
5. Coordination of intratumoral immune reaction and human colorectal cancer recurrence. Camus M; Tosolini M; Mlecnik B; Pagès F; Kirilovsky A; Berger A; Costes A; Bindea G; Charoentong P; Bruneval P; Trajanoski Z; Fridman WH; Galon J Cancer Res; 2009 Mar; 69(6):2685-93. PubMed ID: 19258510 [TBL] [Abstract][Full Text] [Related]
6. Immune infiltration in human tumors: a prognostic factor that should not be ignored. Pagès F; Galon J; Dieu-Nosjean MC; Tartour E; Sautès-Fridman C; Fridman WH Oncogene; 2010 Feb; 29(8):1093-102. PubMed ID: 19946335 [TBL] [Abstract][Full Text] [Related]
7. Characteristics and clinical impacts of the immune environments in colorectal and renal cell carcinoma lung metastases: influence of tumor origin. Remark R; Alifano M; Cremer I; Lupo A; Dieu-Nosjean MC; Riquet M; Crozet L; Ouakrim H; Goc J; Cazes A; Fléjou JF; Gibault L; Verkarre V; Régnard JF; Pagès ON; Oudard S; Mlecnik B; Sautès-Fridman C; Fridman WH; Damotte D Clin Cancer Res; 2013 Aug; 19(15):4079-91. PubMed ID: 23785047 [TBL] [Abstract][Full Text] [Related]
8. Therapeutic Lymphoid Organogenesis in the Tumor Microenvironment. Weinstein AM; Storkus WJ Adv Cancer Res; 2015; 128():197-233. PubMed ID: 26216634 [TBL] [Abstract][Full Text] [Related]
9. Effect of tumor cells and tumor microenvironment on NK-cell function. Vitale M; Cantoni C; Pietra G; Mingari MC; Moretta L Eur J Immunol; 2014 Jun; 44(6):1582-92. PubMed ID: 24777896 [TBL] [Abstract][Full Text] [Related]
10. Tertiary lymphoid tissue in the tumor microenvironment: from its occurrence to immunotherapeutic implications. Di Caro G; Castino GF; Bergomas F; Cortese N; Chiriva-Internati M; Grizzi F; Mantovani A; Marchesi F Int Rev Immunol; 2015 Mar; 34(2):123-33. PubMed ID: 25901857 [TBL] [Abstract][Full Text] [Related]
17. Variation of tumor-infiltrating lymphocytes in human cancers: controversy on clinical significance. Sasada T; Suekane S Immunotherapy; 2011 Oct; 3(10):1235-51. PubMed ID: 21995574 [TBL] [Abstract][Full Text] [Related]
18. Immune cell infiltrate differences in pilocytic astrocytoma and glioblastoma: evidence of distinct immunological microenvironments that reflect tumor biology. Yang I; Han SJ; Sughrue ME; Tihan T; Parsa AT J Neurosurg; 2011 Sep; 115(3):505-11. PubMed ID: 21663411 [TBL] [Abstract][Full Text] [Related]
19. Immune cell infiltration of primary and metastatic lesions: mechanisms and clinical impact. Talmadge JE Semin Cancer Biol; 2011 Apr; 21(2):131-8. PubMed ID: 21145968 [TBL] [Abstract][Full Text] [Related]
20. Modulation of neutrophil granulocytes in the tumor microenvironment: mechanisms and consequences for tumor progression. Dumitru CA; Lang S; Brandau S Semin Cancer Biol; 2013 Jun; 23(3):141-8. PubMed ID: 23485549 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]